Raras
Buscar doenças, sintomas, genes...
Displasia acromélica
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A displasia frontonasal (DFN) é uma malformação congênita da parte média da face. Para o diagnóstico de DFN, o paciente deve apresentar pelo menos duas das seguintes características: hipertelorismo, raiz nasal larga, fenda vertical na linha média do nariz e/ou lábio superior, fenda nas asas do nariz, ponta nasal malformada, encefalocele ou padrão de implantação capilar em forma de V na testa. A causa da DFN permanece desconhecida. A DFN parece ser esporádica (aleatória) e múltiplos fatores ambientais são sugeridos como possíveis causas para a síndrome. No entanto, em algumas famílias foram relatados múltiplos casos de DFN, o que sugere uma causa genética para a DFN.

Publicações científicas
31 artigos
Último publicado: 2024 Sep
Medicamentos
2 registrados
THEOPHYLLINE ANHYDROUS, SOMATROPIN

Tem tratamento?

2 medicamentos registrados
Ver detalhes, fases e interações →
THEOPHYLLINE ANHYDROUSSOMATROPIN
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
134 sintomas
😀
Face
50 sintomas
🧬
Pele e cabelo
37 sintomas
🧠
Neurológico
37 sintomas
👁️
Olhos
27 sintomas
📏
Crescimento
26 sintomas

+ 223 sintomas em outras categorias

Características mais comuns

Orelhas com rotação posterior
Hirsutismo frontal
Epífises metacarpais em forma de cone
Anormalidade no EMG
Estrutura óssea anormal
Distonia laríngea
635sintomas
Sem dados (635)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 635 características clínicas mais associadas, ordenadas por frequência.

Orelhas com rotação posteriorPosteriorly rotated ears
Hirsutismo frontalFrontal hirsutism
Epífises metacarpais em forma de coneCone-shaped metacarpal epiphyses
Anormalidade no EMGEMG abnormality
Estrutura óssea anormalAbnormal bone structure

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa2desde 2024
Total histórico31PubMed
Últimos 10 anos23publicações
Pico20215 papers
Linha do tempo
2024Hoje · 2026📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

20 genes identificados com associação a esta condição.

CERS3Ceramide synthase 3Candidate gene tested inTolerante
FUNÇÃO

Ceramide synthase that catalyzes the transfer of the acyl chain from acyl-CoA to a sphingoid base, with high selectivity toward very- and ultra-long-chain fatty acyl-CoA (chain length greater than C22) (PubMed:17977534, PubMed:22038835, PubMed:26887952). N-acylates sphinganine and sphingosine bases to form dihydroceramides and ceramides in de novo synthesis and salvage pathways, respectively (PubMed:17977534, PubMed:22038835, PubMed:26887952). It is crucial for the synthesis of ultra-long-chain

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Sphingolipid de novo biosynthesis
MECANISMO DE DOENÇA

Ichthyosis, congenital, autosomal recessive 9

A form of autosomal recessive congenital ichthyosis, a disorder of keratinization with abnormal differentiation and desquamation of the epidermis, resulting in abnormal skin scaling over the whole body. The main skin phenotypes are lamellar ichthyosis (LI) and non-bullous congenital ichthyosiform erythroderma (NCIE), although phenotypic overlap within the same patient or among patients from the same family can occur. Lamellar ichthyosis is a condition often associated with an embedment in a collodion-like membrane at birth; skin scales later develop, covering the entire body surface. Non-bullous congenital ichthyosiform erythroderma characterized by fine whitish scaling on an erythrodermal background; larger brownish scales are present on the buttocks, neck and legs.

OUTRAS DOENÇAS (3)
autosomal recessive congenital ichthyosis 9congenital non-bullous ichthyosiform erythrodermaWeill-Marchesani 4 syndrome, recessive
HGNC:23752UniProt:Q8IU89
PRMT7Protein arginine N-methyltransferase 7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Arginine methyltransferase that can both catalyze the formation of omega-N monomethylarginine (MMA) and symmetrical dimethylarginine (sDMA), with a preference for the formation of MMA. Specifically mediates the symmetrical dimethylation of arginine residues in the small nuclear ribonucleoproteins Sm D1 (SNRPD1) and Sm D3 (SNRPD3); such methylation being required for the assembly and biogenesis of snRNP core particles. Specifically mediates the symmetric dimethylation of histone H4 'Arg-3' to for

LOCALIZAÇÃO

Cytoplasm, cytosolNucleus

VIAS BIOLÓGICAS (1)
RMTs methylate histone arginines
MECANISMO DE DOENÇA

Short stature, brachydactyly, impaired intellectual developmental, and seizures

An autosomal recessive disease characterized by developmental delay, learning disabilities, mild intellectual disability, delayed speech, and skeletal abnormalities. Skeletal features include short stature, brachydactyly, and short metacarpals and metatarsals.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
40.7 TPM
Cérebro - Hemisfério cerebelar
38.3 TPM
Nervo tibial
21.7 TPM
Ovário
19.6 TPM
Cervix Endocervix
18.6 TPM
OUTRAS DOENÇAS (1)
short stature-brachydactyly-obesity-global developmental delay syndrome
HGNC:25557UniProt:Q9NVM4
GNASProtein ALEXDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

May inhibit the adenylyl cyclase-stimulating activity of guanine nucleotide-binding protein G(s) subunit alpha which is produced from the same locus in a different open reading frame

LOCALIZAÇÃO

Cell membraneCell projection, ruffle

VIAS BIOLÓGICAS (10)
G alpha (s) signalling eventsProstacyclin signalling through prostacyclin receptorADORA2B mediated anti-inflammatory cytokines productionGPER1 signalingG alpha (i) signalling events
EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
1324.4 TPM
Tireoide
727.3 TPM
Hipotálamo
548.6 TPM
Brain Frontal Cortex BA9
501.2 TPM
Cérebro - Hemisfério cerebelar
474.1 TPM
OUTRAS DOENÇAS (12)
progressive osseous heteroplasiapituitary adenoma 3, multiple typespseudohypoparathyroidism type 1CMcCune-Albright syndrome
HGNC:4392UniProt:P84996
ADAMTS17A disintegrin and metalloproteinase with thrombospondin motifs 17Disease-causing germline mutation(s) inTolerante
LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
O-glycosylation of TSR domain-containing proteins
MECANISMO DE DOENÇA

Weill-Marchesani syndrome 4

An autosomal recessive syndrome characterized by lenticular myopia, ectopia lentis, glaucoma, spherophakia and short stature. Brachydactyly and decreased joint flexibility are present in some patients.

INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (2)
Weill-Marchesani 4 syndrome, recessiveWeill-Marchesani syndrome
HGNC:17109UniProt:Q8TE56
IFT140Intraflagellar transport protein 140 homologDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the IFT complex A (IFT-A), a complex required for retrograde ciliary transport and entry into cilia of G protein-coupled receptors (GPCRs) (PubMed:20889716, PubMed:22503633). Plays a pivotal role in proper development and function of ciliated cells through its role in ciliogenesis and/or cilium maintenance (PubMed:22503633). Required for the development and maintenance of the outer segments of rod and cone photoreceptor cells. Plays a role in maintenance and the delivery of opsin to

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell projection, cilium

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateIntraflagellar transport
MECANISMO DE DOENÇA

Short-rib thoracic dysplasia 9 with or without polydactyly

A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome. SRTD9 is characterized by phalangeal cone-shaped epiphyses, chronic renal disease, nearly constant retinal dystrophy, and mild radiographic abnormality of the proximal femur. Occasional features include short stature, cerebellar ataxia, and hepatic fibrosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
59.8 TPM
Testículo
47.9 TPM
Pituitária
34.4 TPM
Ovário
31.1 TPM
Cervix Endocervix
29.6 TPM
OUTRAS DOENÇAS (8)
retinitis pigmentosa 80cranioectodermal dysplasia 5short-rib thoracic dysplasia 9 with or without polydactylyJeune syndrome
HGNC:29077UniProt:Q96RY7
ADAMTS10A disintegrin and metalloproteinase with thrombospondin motifs 10Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Metalloprotease that participate in microfibrils assembly. Microfibrils are extracellular matrix components occurring independently or along with elastin in the formation of elastic tissues

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
O-glycosylation of TSR domain-containing proteins
MECANISMO DE DOENÇA

Weill-Marchesani syndrome 1

A rare connective tissue disorder characterized by short stature, brachydactyly, joint stiffness, and eye abnormalities including microspherophakia, ectopia lentis, severe myopia and glaucoma.

INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (2)
Weill-Marchesani syndrome 1Weill-Marchesani syndrome
HGNC:13201UniProt:Q9H324
TRPS1Zinc finger transcription factor Trps1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcriptional repressor. Binds specifically to GATA sequences and represses expression of GATA-regulated genes at selected sites and stages in vertebrate development. Regulates chondrocyte proliferation and differentiation. Executes multiple functions in proliferating chondrocytes, expanding the region of distal chondrocytes, activating proliferation in columnar cells and supporting the differentiation of columnar into hypertrophic chondrocytes

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Tricho-rhino-phalangeal syndrome 1

Autosomal dominant disorder characterized by craniofacial and skeletal abnormalities. It is allelic with tricho-rhino-phalangeal type 3. Typical features include sparse scalp hair, a bulbous tip of the nose, protruding ears, a long flat philtrum and a thin upper vermilion border. Skeletal defects include cone-shaped epiphyses at the phalanges, hip malformations and short stature.

EXPRESSÃO TECIDUAL(Ubíquo)
Mama
25.2 TPM
Vagina
18.8 TPM
Cervix Ectocervix
15.4 TPM
Glândula salivar
13.5 TPM
Esôfago - Mucosa
13.1 TPM
OUTRAS DOENÇAS (3)
obsolete trichorhinophalangeal syndrome, type IIItrichorhinophalangeal syndrome type Itrichorhinophalangeal syndrome type II
HGNC:12340UniProt:Q9UHF7
LTBP3Latent-transforming growth factor beta-binding protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May play an integral structural role in elastic-fiber architectural organization and/or assembly

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (2)
Molecules associated with elastic fibresTGF-beta receptor signaling activates SMADs
MECANISMO DE DOENÇA

Glaucoma 3, primary congenital, D

An autosomal recessive form of primary congenital glaucoma (PCG). PCG is characterized by marked increase of intraocular pressure at birth or early childhood, large ocular globes (buphthalmos) and corneal edema. It results from developmental defects of the trabecular meshwork and anterior chamber angle of the eye that prevent adequate drainage of aqueous humor.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
369.7 TPM
Artéria tibial
212.2 TPM
Artéria coronária
204.8 TPM
Útero
192.4 TPM
Ovário
192.2 TPM
OUTRAS DOENÇAS (4)
geleophysic dysplasia 3brachyolmia-amelogenesis imperfecta syndromeAcromicric dysplasiageleophysic dysplasia
HGNC:6716UniProt:Q14767
ADAMTSL2ADAMTS-like protein 2Disease-causing germline mutation(s) inRestrito
LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (1)
O-glycosylation of TSR domain-containing proteins
MECANISMO DE DOENÇA

Geleophysic dysplasia 1

An autosomal recessive disorder characterized by severe short stature, short hands and feet, joint limitations, and skin thickening. Radiologic features include delayed bone age, cone-shaped epiphyses, shortened long tubular bones, and ovoid vertebral bodies. Affected individuals have characteristic facial features including a 'happy' face with full cheeks, shortened nose, hypertelorism, long and flat philtrum, and thin upper lip. Other distinctive features include progressive cardiac valvular thickening often leading to an early death, toe walking, tracheal stenosis, respiratory insufficiency, and lysosomal-like storage vacuoles in various tissues.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (3)
geleophysic dysplasia 1geleophysic dysplasiaEhlers-Danlos syndrome, dermatosparaxis type
HGNC:14631UniProt:Q86TH1
RAD21Double-strand-break repair protein rad21 homologCandidate gene tested inAltamente restrito
FUNÇÃO

As a member of the cohesin complex, involved in sister chromatid cohesion from the time of DNA replication in S phase to their segregation in mitosis, a function that is essential for proper chromosome segregation, post-replicative DNA repair, and the prevention of inappropriate recombination between repetitive regions (PubMed:11509732). The cohesin complex may also play a role in spindle pole assembly during mitosis (PubMed:11590136). In interphase, cohesins may function in the control of gene

LOCALIZAÇÃO

NucleusNucleus matrixChromosomeChromosome, centromereCytoplasm, cytoskeleton, spindle poleCytoplasm, cytosol

VIAS BIOLÓGICAS (2)
Establishment of Sister Chromatid CohesionResolution of Sister Chromatid Cohesion
MECANISMO DE DOENÇA

Cornelia de Lange syndrome 4 with or without midline brain defects

A form of Cornelia de Lange syndrome, a clinically heterogeneous developmental disorder associated with malformations affecting multiple systems. It is characterized by facial dysmorphisms, abnormal hands and feet, growth delay, cognitive retardation, hirsutism, gastroesophageal dysfunction and cardiac, ophthalmologic and genitourinary anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
148.7 TPM
Cérebro - Hemisfério cerebelar
109.2 TPM
Esôfago - Muscular
99.4 TPM
Testículo
98.1 TPM
Tireoide
90.8 TPM
OUTRAS DOENÇAS (4)
Cornelia de Lange syndrome 4Mungan syndrometrichorhinophalangeal syndrome type IICornelia de Lange syndrome
HGNC:9811UniProt:O60216
GDF5Growth/differentiation factor 5Candidate gene tested inTolerante
FUNÇÃO

Growth factor involved in bone and cartilage formation. During cartilage development regulates differentiation of chondrogenic tissue through two pathways. Firstly, positively regulates differentiation of chondrogenic tissue through its binding of high affinity with BMPR1B and of less affinity with BMPR1A, leading to induction of SMAD1-SMAD5-SMAD8 complex phosphorylation and then SMAD protein signaling transduction (PubMed:15530414, PubMed:21976273, PubMed:24098149, PubMed:25092592). Secondly, n

LOCALIZAÇÃO

SecretedCell membrane

VIAS BIOLÓGICAS (1)
Molecules associated with elastic fibres
MECANISMO DE DOENÇA

Acromesomelic dysplasia 2A

A form of acromesomelic dysplasia, a skeletal disorder characterized by short stature, very short limbs and hand/foot malformations. The severity of limb abnormalities increases from proximal to distal with profoundly affected hands and feet showing brachydactyly and/or rudimentary fingers (knob-like fingers). AMD2A is an autosomal recessive form characterized by normal axial skeletons and missing or fused skeletal elements within the hands and feet.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fibroblastos
7.0 TPM
Glândula salivar
4.0 TPM
Cólon sigmoide
2.0 TPM
Pulmão
1.8 TPM
Testículo
1.3 TPM
OUTRAS DOENÇAS (13)
multiple synostoses syndrome 2symphalangism, proximal, 1Bbrachydactyly type A2brachydactyly type C
HGNC:4220UniProt:P43026
PRKAR1AcAMP-dependent protein kinase type I-alpha regulatory subunitDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Regulatory subunit of the cAMP-dependent protein kinases involved in cAMP signaling in cells

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (10)
PKA activationGPER1 signalingCREB1 phosphorylation through the activation of Adenylate CyclaseDARPP-32 eventsHigh laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
MECANISMO DE DOENÇA

Carney complex 1

CNC is a multiple neoplasia syndrome characterized by spotty skin pigmentation, cardiac and other myxomas, endocrine tumors, and psammomatous melanotic schwannomas.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
152.7 TPM
Ovário
151.5 TPM
Aorta
138.6 TPM
Útero
138.3 TPM
Tecido adiposo
129.4 TPM
OUTRAS DOENÇAS (9)
familial atrial myxomapigmented nodular adrenocortical disease, primary, 1Acrodysostosis 1 with or without hormone resistanceCarney complex, type 1
HGNC:9388UniProt:P10644
PDE4D3',5'-cyclic-AMP phosphodiesterase 4DDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes

LOCALIZAÇÃO

Apical cell membraneCytoplasmMembraneCytoplasm, cytoskeletonCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (2)
G alpha (s) signalling eventsDARPP-32 events
EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
23.1 TPM
Artéria tibial
19.8 TPM
Cólon sigmoide
16.6 TPM
Bladder
12.5 TPM
Próstata
11.2 TPM
OUTRAS DOENÇAS (3)
acrodysostosis 2 with or without hormone resistancechromosome 5q12 deletion syndromeacrodysostosis
HGNC:8783UniProt:Q08499
IFT172Intraflagellar transport protein 172 homologCandidate gene tested inTolerante
FUNÇÃO

Required for the maintenance and formation of cilia. Plays an indirect role in hedgehog (Hh) signaling, cilia being required for all activity of the hedgehog pathway (By similarity)

LOCALIZAÇÃO

Cell projection, cilium

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateIntraflagellar transport
MECANISMO DE DOENÇA

Short-rib thoracic dysplasia 10 with or without polydactyly

A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
57.3 TPM
Pituitária
51.2 TPM
Ovário
41.6 TPM
Tireoide
30.7 TPM
Cerebelo
30.2 TPM
OUTRAS DOENÇAS (7)
retinitis pigmentosa 71Bardet-Biedl syndrome 20short-rib thoracic dysplasia 10 with or without polydactylyshort-rib thoracic dysplasia 9 with or without polydactyly
HGNC:30391UniProt:Q9UG01
LTBP2Latent-transforming growth factor beta-binding protein 2Disease-causing germline mutation(s) inRestrito
FUNÇÃO

May play an integral structural role in elastic-fiber architectural organization and/or assembly

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (2)
Molecules associated with elastic fibresTGF-beta receptor signaling activates SMADs
MECANISMO DE DOENÇA

Glaucoma 3, primary congenital, D

An autosomal recessive form of primary congenital glaucoma (PCG). PCG is characterized by marked increase of intraocular pressure at birth or early childhood, large ocular globes (buphthalmos) and corneal edema. It results from developmental defects of the trabecular meshwork and anterior chamber angle of the eye that prevent adequate drainage of aqueous humor.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
706.6 TPM
Artéria coronária
329.4 TPM
Artéria tibial
259.7 TPM
Pulmão
139.3 TPM
Tireoide
137.8 TPM
OUTRAS DOENÇAS (6)
microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucomaWeill-Marchesani syndrome 3glaucoma 3, primary congenital, Dglaucoma secondary to spherophakia/ectopia lentis and megalocornea
HGNC:6715UniProt:Q14767
FBN1Fibrillin-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Structural component of the 10-12 nm diameter microfibrils of the extracellular matrix, which conveys both structural and regulatory properties to load-bearing connective tissues (PubMed:15062093, PubMed:1860873). Fibrillin-1-containing microfibrils provide long-term force bearing structural support (PubMed:27026396). In tissues such as the lung, blood vessels and skin, microfibrils form the periphery of the elastic fiber, acting as a scaffold for the deposition of elastin (PubMed:27026396). In

LOCALIZAÇÃO

SecretedSecreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
MECANISMO DE DOENÇA

Marfan syndrome

A hereditary disorder of connective tissue that affects the skeletal, ocular, and cardiovascular systems. A wide variety of skeletal abnormalities occurs with Marfan syndrome, including scoliosis, chest wall deformity, tall stature, abnormal joint mobility. Ectopia lentis occurs in most of the patients and is almost always bilateral. The leading cause of premature death is progressive dilation of the aortic root and ascending aorta, causing aortic incompetence and dissection. Neonatal Marfan syndrome is the most severe form resulting in death from cardiorespiratory failure in the first few years of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
295.9 TPM
Artéria coronária
63.8 TPM
Aorta
63.1 TPM
Tecido adiposo
54.3 TPM
Esôfago - Junção
48.0 TPM
OUTRAS DOENÇAS (14)
geleophysic dysplasia 2Weill-Marchesani syndrome 2, dominantMASS syndromeectopia lentis 1, isolated, autosomal dominant
HGNC:3603UniProt:P35555
IHHIndian hedgehog proteinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Plays a role in embryonic morphogenesis; it is involved in the regulation of endochondral skeleton formation, and the development of retinal pigment epithelium (RPE), photoreceptors and periocular tissues (By similarity) The C-terminal part of the indian hedgehog protein precursor displays an autoproteolysis and a cholesterol transferase activity (By similarity). Both activities result in the cleavage of the full-length protein into two parts followed by the covalent attachment of a cholesterol

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum membraneGolgi apparatus membraneSecreted

VIAS BIOLÓGICAS (6)
RUNX2 regulates chondrocyte maturationHedgehog 'on' stateActivation of SMOLigand-receptor interactionsRelease of Hh-Np from the secreting cell
MECANISMO DE DOENÇA

Brachydactyly A1

An autosomal dominant form of brachydactyly, a group of inherited malformations characterized by shortening of the digits due to abnormal development of the phalanges and/or the metacarpals. Brachydactyly type A1 is characterized by middle phalanges of all the digits rudimentary or fused with the terminal phalanges. The proximal phalanges of the thumbs and big toes are short. Some BDA1 affected individuals exhibit short stature.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cólon transverso
30.7 TPM
Intestino delgado
15.4 TPM
Estômago
12.4 TPM
Próstata
3.0 TPM
Fígado
2.0 TPM
OUTRAS DOENÇAS (2)
acrocapitofemoral dysplasiabrachydactyly type A1
HGNC:5956UniProt:Q14623
EXT1Exostosin-1Candidate gene tested inAltamente restrito
FUNÇÃO

Glycosyltransferase forming with EXT2 the heterodimeric heparan sulfate polymerase which catalyzes the elongation of the heparan sulfate glycan backbone (PubMed:10639137, PubMed:22660413, PubMed:36402845, PubMed:36593275, PubMed:9620772). Glycan backbone extension consists in the alternating transfer of (1->4)-beta-D-GlcA and (1->4)-alpha-D-GlcNAc residues from their respective UDP-sugar donors. Both EXT1 and EXT2 are required for the full activity of the polymerase since EXT1 bears the N-acetyl

LOCALIZAÇÃO

Golgi apparatus membraneGolgi apparatus, cis-Golgi network membraneEndoplasmic reticulum membrane

VIAS BIOLÓGICAS (2)
HS-GAG biosynthesisDefective EXT2 causes exostoses 2
MECANISMO DE DOENÇA

Hereditary multiple exostoses 1

EXT is a genetically heterogeneous bone disorder caused by genes segregating on human chromosomes 8, 11, and 19 and designated EXT1, EXT2 and EXT3 respectively. EXT is a dominantly inherited skeletal disorder primarily affecting endochondral bone during growth. The disease is characterized by formation of numerous cartilage-capped, benign bone tumors (osteocartilaginous exostoses or osteochondromas) that are often accompanied by skeletal deformities and short stature. In a small percentage of cases exostoses have exhibited malignant transformation resulting in an osteosarcoma or chondrosarcoma. Osteochondromas development can also occur as a sporadic event.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
72.2 TPM
Fibroblastos
49.8 TPM
Artéria tibial
39.0 TPM
Artéria coronária
34.6 TPM
Pulmão
23.8 TPM
OUTRAS DOENÇAS (4)
chondrosarcomaexostoses, multiple, type 1trichorhinophalangeal syndrome type IIhereditary multiple osteochondromas
HGNC:3512UniProt:Q16394
FLNAFilamin-ADisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interaction with FLNB may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking (By similarity). Involved in cilio

LOCALIZAÇÃO

Cytoplasm, cell cortexCytoplasm, cytoskeletonPerikaryonCell projection, growth coneCell projection, podosome

VIAS BIOLÓGICAS (5)
RHO GTPases activate PAKsCell-extracellular matrix interactionsOAS antiviral responseGP1b-IX-V activation signallingPlatelet degranulation
MECANISMO DE DOENÇA

Periventricular nodular heterotopia 1

A developmental disorder characterized by the presence of periventricular nodules of cerebral gray matter, resulting from a failure of neurons to migrate normally from the lateral ventricular proliferative zone, where they are formed, to the cerebral cortex. PVNH1 is an X-linked dominant form. Heterozygous females have normal intelligence but suffer from seizures and various manifestations outside the central nervous system, especially related to the vascular system. Hemizygous affected males die in the prenatal or perinatal period.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
4950.9 TPM
Cólon sigmoide
3958.6 TPM
Esôfago - Muscular
3824.4 TPM
Aorta
3732.4 TPM
Esôfago - Junção
3728.0 TPM
OUTRAS DOENÇAS (15)
heterotopia, periventricular, X-linked dominantMelnick-Needles syndromeintestinal pseudoobstruction, neuronal, chronic idiopathic, X-linkedfrontometaphyseal dysplasia 1
HGNC:3754UniProt:P21333
SMAD4SMAD family member 4Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

In muscle physiology, plays a central role in the balance between atrophy and hypertrophy. When recruited by MSTN, promotes atrophy response via phosphorylated SMAD2/4. MSTN decrease causes SMAD4 release and subsequent recruitment by the BMP pathway to promote hypertrophy via phosphorylated SMAD1/5/8. Acts synergistically with SMAD1 and YY1 in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression. Binds to SMAD binding elements (SBEs) (5'-GTCT/AGAC-3') within BMP response el

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (10)
Transcriptional regulation of pluripotent stem cellsSMAD2/SMAD3:SMAD4 heterotrimer regulates transcriptionDownregulation of SMAD2/3:SMAD4 transcriptional activitySignaling by ActivinSignaling by NODAL
MECANISMO DE DOENÇA

Pancreatic cancer

A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
37.2 TPM
Ovário
34.9 TPM
Cervix Endocervix
34.5 TPM
Cérebro - Hemisfério cerebelar
32.5 TPM
Nervo tibial
32.3 TPM
OUTRAS DOENÇAS (7)
Myhre syndromejuvenile polyposis syndromejuvenile polyposis/hereditary hemorrhagic telangiectasia syndromefamilial pancreatic carcinoma
HGNC:6770UniProt:Q13485

Medicamentos e terapias

THEOPHYLLINE ANHYDROUSPhase 2

Mecanismo: Phosphodiesterase 4 inhibitor

SOMATROPINPhase 2

Mecanismo: Growth hormone receptor agonist

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

672 variantes patogênicas registradas no ClinVar.

🧬 CERS3: GRCh38/hg38 15q26.1-26.3(chr15:90068508-101888837)x3 ()
🧬 CERS3: NM_001378789.1(CERS3):c.363del (p.Asn122fs) ()
🧬 CERS3: NM_001378789.1(CERS3):c.174-2A>G ()
🧬 CERS3: NM_001378789.1(CERS3):c.1006C>T (p.Gln336Ter) ()
🧬 CERS3: GRCh37/hg19 15q26.1-26.3(chr15:90569376-102369410)x1 ()
Ver todas no ClinVar

Vias biológicas (Reactome)

78 vias biológicas associadas aos genes desta condição.

Sphingolipid de novo biosynthesis RMTs methylate histone arginines GNAS1 GNAS2 GNAS G alpha (s):GTP:SRC dissociates G alpha (s):GTP:SRC catalyzes SRC to p-Y419-SRC G protein alpha (s):GTP binds SRC Defective B3GALTL causes PpS O-glycosylation of TSR domain-containing proteins Hedgehog 'off' state Intraflagellar transport Defective EXT1 causes exostoses 1, TRPS2 and CHDS Molecules associated with elastic fibres TGF-beta receptor signaling activates SMADs Meiotic synapsis Separation of Sister Chromatids Establishment of Sister Chromatid Cohesion Cohesin Loading onto Chromatin Resolution of Sister Chromatid Cohesion SUMOylation of DNA damage response and repair proteins Estrogen-dependent gene expression PKA activation PKA activation in glucagon signalling DARPP-32 events Glucagon-like Peptide-1 (GLP1) regulates insulin secretion Vasopressin regulates renal water homeostasis via Aquaporins CREB1 phosphorylation through the activation of Adenylate Cyclase GPER1 signaling ADORA2B mediated anti-inflammatory cytokines production FCGR3A-mediated IL10 synthesis ALK mutants bind TKIs Signaling by ALK fusions and activated point mutants Factors involved in megakaryocyte development and platelet production High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells G alpha (s) signalling events Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells Degradation of the extracellular matrix Elastic fibre formation Integrin cell surface interactions Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) Post-translational protein phosphorylation Class B/2 (Secretin family receptors) Hedgehog ligand biogenesis Release of Hh-Np from the secreting cell Ligand-receptor interactions Hedgehog 'on' state Activation of SMO HHAT G278V doesn't palmitoylate Hh-Np RUNX2 regulates chondrocyte maturation Formation of lateral plate mesoderm HS-GAG biosynthesis Defective EXT2 causes exostoses 2 Platelet degranulation GP1b-IX-V activation signalling Cell-extracellular matrix interactions RHO GTPases activate PAKs OAS antiviral response Signaling by NODAL Signaling by Activin Signaling by BMP Downregulation of SMAD2/3:SMAD4 transcriptional activity SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription SMAD4 MH2 Domain Mutants in Cancer SMAD2/3 MH2 Domain Mutants in Cancer Transcriptional regulation of pluripotent stem cells Ub-specific processing proteases RUNX2 regulates bone development RUNX3 regulates CDKN1A transcription RUNX3 regulates BCL2L11 (BIM) transcription FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes FOXO-mediated transcription of cell cycle genes Cardiogenesis SARS-CoV-1 targets host intracellular signalling and regulatory pathways Germ layer formation at gastrulation Formation of definitive endoderm TGFBR3 expression Transcriptional regulation of brown and beige adipocyte differentiation by EBF2

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 22
Medicamentos catalogadosEnsaios clínicos· 2 medicamentos · 0 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Displasia acromélica

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
23 papers (10 anos)
#1

Case Report: Two different acromelic dysplasia phenotypes in a Chinese family caused by a missense mutation in FBN1 and a literature review.

Frontiers in pediatrics2024

Acromelic dysplasia caused by FBN1 mutation includes acromicric dysplasia (AD), geleophysic dysplasia 2 (GD2), and Weill-Marchesani syndrome 2 (WMS2). All three diseases share severe short stature and brachydactyly. Besides phenotypic similarity, there is a molecular genetic overlap among them, as identical FBN1 gene mutations have been identified in patients with AD, GD2, and WMS2. However, no family with different acromelic dysplasia phenotypes due to the same variant has been described in English reports. The proband presented with typical facial features, severe short stature, short limbs, stubby hands and feet and radiological abnormalities. Her elder sister and mother had similar physical features. In addition, her elder sister was found to have aortic valve stenosis by echocardiography. Mutation analysis demonstrated a heterozygous missense mutation, c.5179C>T (p.Arg1727Trp) in exon 42 of the FBN1. The proband and her mother were diagnosed with AD, and her elder sister with GD2. The proband was treated with recombinant human growth hormone (rhGH) and had a body length gain of 0.72 SDS in half a year. These findings expand the phenotypic spectrum of FBN1 gene mutations and highlight that identical FBN1 genotypes can result in different phenotypes of acromelic dysplasia in a family. The efficacy of rhGH therapy in patients with acromelic dysplasia is controversial. More follow-up is needed on the long-term efficacy of rhGH therapy.

#2

Fibrillin-1 Gene Variant p.Gly1754Ser Associated With Weill-Marchesani Syndrome Type 2: A Case Report.

Cureus2024 Sep

Weill-Marchesani syndrome (WMS) is a rare connective tissue disorder characterized by severe short stature, small hands and feet, joint stiffness, eye abnormalities such as microspherophakia, ectopia of lenses, severe myopia, glaucoma, and heart defects. This case study describes a nine-year-old female child with WMS syndrome type 2 and heterozygous pathogenic variant p.Gly1754Ser in the fibrillin-1 gene, identified on whole exome sequencing. Two individuals with WMS with the p.Gly1754Ser variant have been previously reported in the medical literature. The present case is the fourteenth case of WMS type 2 with fibrillin-1 gene mutation in the medical literature, to the best of the author's knowledge.

#3

TGF-β and BMP Signaling Pathways in Skeletal Dysplasia with Short and Tall Stature.

Annual review of genomics and human genetics2023 Aug 25

The transforming growth factor β (TGF-β) and bone morphogenetic protein (BMP) signaling pathways play a pivotal role in bone development and skeletal health. More than 30 different types of skeletal dysplasia are now known to be caused by pathogenic variants in genes that belong to the TGF-β superfamily and/or regulate TGF-β/BMP bioavailability. This review describes the latest advances in skeletal dysplasia that is due to impaired TGF-β/BMP signaling and results in short stature (acromelic dysplasia and cardiospondylocarpofacial syndrome) or tall stature (Marfan syndrome). We thoroughly describe the clinical features of the patients, the underlying genetic findings, and the pathomolecular mechanisms leading to disease, which have been investigated mainly using patient-derived skin fibroblasts and mouse models. Although no pharmacological treatment is yet available for skeletal dysplasia due to impaired TGF-β/BMP signaling, in recent years advances in the use of drugs targeting TGF-β have been made, and we also discuss these advances.

#4

Secreted ADAMTS-like 2 promotes myoblast differentiation by potentiating WNT signaling.

Matrix biology : journal of the International Society for Matrix Biology2023 Jun

Myogenesis is the process that generates multinucleated contractile myofibers from muscle stem cells during skeletal muscle development and regeneration. Myogenesis is governed by myogenic regulatory transcription factors, including MYOD1. Here, we identified the secreted matricellular protein ADAMTS-like 2 (ADAMTSL2) as part of a Wnt-dependent positive feedback loop, which augmented or sustained MYOD1 expression and thus promoted myoblast differentiation. ADAMTSL2 depletion resulted in severe retardation of myoblast differentiation in vitro and its ablation in myogenic precursor cells resulted in aberrant skeletal muscle architecture. Mechanistically, ADAMTSL2 potentiated WNT signaling by binding to WNT ligands and WNT receptors. We identified the WNT-binding ADAMTSL2 peptide, which was sufficient to promote myogenesis in vitro. Since ADAMTSL2 was previously described as a negative regulator of TGFβ signaling in fibroblasts, ADAMTSL2 now emerges as a signaling hub that could integrate WNT, TGFβ and potentially other signaling pathways within the dynamic microenvironment of differentiating myoblasts during skeletal muscle development and regeneration.

#5

The fibrillinopathies: New insights with focus on the paradigm of opposing phenotypes for both FBN1 and FBN2.

Human mutation2022 Jul

Different pathogenic variants in the fibrillin-1 gene (FBN1) cause Marfan syndrome and acromelic dysplasias. Whereas the musculoskeletal features of Marfan syndrome involve tall stature, arachnodactyly, joint hypermobility, and muscle hypoplasia, acromelic dysplasia patients present with short stature, brachydactyly, stiff joints, and hypermuscularity. Similarly, pathogenic variants in the fibrillin-2 gene (FBN2) cause either a Marfanoid congenital contractural arachnodactyly or a FBN2-related acromelic dysplasia that most prominently presents with brachydactyly. The phenotypic and molecular resemblances between both the FBN1 and FBN2-related disorders suggest that reciprocal pathomechanistic lessons can be learned. In this review, we provide an updated overview and comparison of the phenotypic and mutational spectra of both the "tall" and "short" fibrillinopathies. The future parallel functional study of both FBN1/2-related disorders will reveal new insights into how pathogenic fibrillin variants differently affect the fibrillin microfibril network and/or growth factor homeostasis in clinically opposite syndromes. This knowledge may eventually be translated into new therapeutic approaches by targeting or modulating the fibrillin microfibril network and/or the signaling pathways under its control.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC5 artigos no totalmostrando 23

2024

Fibrillin-1 Gene Variant p.Gly1754Ser Associated With Weill-Marchesani Syndrome Type 2: A Case Report.

Cureus
2024

Case Report: Two different acromelic dysplasia phenotypes in a Chinese family caused by a missense mutation in FBN1 and a literature review.

Frontiers in pediatrics
2023

TGF-β and BMP Signaling Pathways in Skeletal Dysplasia with Short and Tall Stature.

Annual review of genomics and human genetics
2023

Secreted ADAMTS-like 2 promotes myoblast differentiation by potentiating WNT signaling.

Matrix biology : journal of the International Society for Matrix Biology
2022

The fibrillinopathies: New insights with focus on the paradigm of opposing phenotypes for both FBN1 and FBN2.

Human mutation
2021

Cooperative Mechanism of ADAMTS/ ADAMTSL and Fibrillin-1 in the Marfan Syndrome and Acromelic Dysplasias.

Frontiers in genetics
2021

Geleophysic dysplasia caused by a mutation in FBN1: A case report.

World journal of clinical cases
2021

A Review of Three Chinese Cases of Acromicric/Geleophysic Dysplasia with FBN1 Mutations.

International journal of general medicine
2021

Geleophysic and acromicric dysplasias: natural history, genotype-phenotype correlations, and management guidelines from 38 cases.

Genetics in medicine : official journal of the American College of Medical Genetics
2020

Separation in genetic pathogenesis of mutations in FBN1-TB5 region between autosomal dominant acromelic dysplasia and Marfan syndrome.

Birth defects research
2021

Acromelic dysplasias: how rare musculoskeletal disorders reveal biological functions of extracellular matrix proteins.

Annals of the New York Academy of Sciences
2019

Genotype-phenotype correlation and expansion of orodental anomalies in LTBP3-related disorders.

Molecular genetics and genomics : MGG
2019

Limb- and tendon-specific Adamtsl2 deletion identifies a role for ADAMTSL2 in tendon growth in a mouse model for geleophysic dysplasia.

Matrix biology : journal of the International Society for Matrix Biology
2019

Fibrillin protein pleiotropy: Acromelic dysplasias.

Matrix biology : journal of the International Society for Matrix Biology
2019

Adamts10 inactivation in mice leads to persistence of ocular microfibrils subsequent to reduced fibrillin-2 cleavage.

Matrix biology : journal of the International Society for Matrix Biology
2018

The Clinical Cases of Geleophysic Dysplasia: One Gene, Different Phenotypes.

Case reports in endocrinology
2018

A report of three families with FBN1-related acromelic dysplasias and review of literature for genotype-phenotype correlation in geleophysic dysplasia.

European journal of medical genetics
2017

A chinese boy with geleophysic dysplasia caused by compound heterozygous mutations in ADAMTSL2.

European journal of medical genetics
2017

Cervical artery dissection expands the cardiovascular phenotype in FBN1-related Weill-Marchesani syndrome.

American journal of medical genetics. Part A
2017

Rapidly progressive mitral valve stenosis in patients with acromelic dysplasia.

Cardiology in the young
2016

Two Patients with Severe Short Stature due to a FBN1 Mutation (p.Ala1728Val) with a Mild Form of Acromicric Dysplasia.

Hormone research in paediatrics
2016

Mutations in LTBP3 cause acromicric dysplasia and geleophysic dysplasia.

Journal of medical genetics
2015

Chondrodysplasias and TGFβ signaling.

BoneKEy reports

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Displasia acromélica.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Displasia acromélica

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Case Report: Two different acromelic dysplasia phenotypes in a Chinese family caused by a missense mutation in FBN1 and a literature review.
    Frontiers in pediatrics· 2024· PMID 39077065mais citado
  2. Fibrillin-1 Gene Variant p.Gly1754Ser Associated With Weill-Marchesani Syndrome Type 2: A Case Report.
    Cureus· 2024· PMID 39421111mais citado
  3. TGF-β and BMP Signaling Pathways in Skeletal Dysplasia with Short and Tall Stature.
    Annual review of genomics and human genetics· 2023· PMID 37624666mais citado
  4. Secreted ADAMTS-like 2 promotes myoblast differentiation by potentiating WNT signaling.
    Matrix biology : journal of the International Society for Matrix Biology· 2023· PMID 37187448mais citado
  5. The fibrillinopathies: New insights with focus on the paradigm of opposing phenotypes for both FBN1 and FBN2.
    Human mutation· 2022· PMID 35419902mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:93436(Orphanet)
  2. MONDO:0019695(MONDO)
  3. GARD:19194(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q55788807(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Displasia acromélica
Compêndio · Raras BR

Displasia acromélica

ORPHA:93436 · MONDO:0019695
CID-11
Medicamentos
2 registrados
MedGen
UMLS
C4736195
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades